Volume 9 Supplement 2

Controversies in breast cancer

Short communications

Edited by William R Miller, Lesley J Fallowfield, Mitch Dowsett, Richard J Santen, James N Ingle

The Symposium and supplement were supported by unrestricted educational grants from AstraZeneca, Novartis, Pfizer and Roche

Controversies in Breast Cancer 2007.

Edinburgh, UK3-4 September 2007

Preface: controversies in breast cancer

Authors: William R Miller

Citation: Breast Cancer Research 2007 9(Suppl 2):S1

Content type: Preface Published on: 20 December 2007
- View Full Text
- View PDF
Psychosocial controversies in breast cancer

Authors: Lesley Fallowfield

Citation: Breast Cancer Research 2007 9(Suppl 2):S2

Content type: Section introduction Published on: 20 December 2007
- View Full Text
- View PDF
The case for user involvement in research: the research priorities of cancer patients

Authors: David NM Wright, Jessica L Corner, Jane B Hopkinson and Claire L Foster

Citation: Breast Cancer Research 2007 9(Suppl 2):S3

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Why patient representation might harm science?

Authors: Jim Cassidy

Citation: Breast Cancer Research 2007 9(Suppl 2):S4

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget

Authors: Emma L Pennery

Citation: Breast Cancer Research 2007 9(Suppl 2):S5

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?

Authors: Jim Cassidy

Citation: Breast Cancer Research 2007 9(Suppl 2):S6

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer

Authors: Lesley Fallowfield

Citation: Breast Cancer Research 2007 9(Suppl 2):S7

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Decision making in local therapy for breast cancer

Authors: Monica Morrow

Citation: Breast Cancer Research 2007 9(Suppl 2):S8

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Benefits of complementary therapies

Authors: Caroline Hoffman

Citation: Breast Cancer Research 2007 9(Suppl 2):S9

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
The dangers of complementary therapy

Authors: Mike Baum

Citation: Breast Cancer Research 2007 9(Suppl 2):S10

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Introduction to sessions on Personalising treatment

Authors: Mitch Dowsett and William R Miller

Citation: Breast Cancer Research 2007 9(Suppl 2):S11

Content type: Section introduction Published on: 20 December 2007
- View Full Text
- View PDF
Personalized surgical treatment of breast cancer

Authors: Monica Morrow

Citation: Breast Cancer Research 2007 9(Suppl 2):S12

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Short-term presurgical treatment for all?

Authors: Mitch Dowsett, Janine Salter, Margaret Hills, Simone Detre, Roger A'Hern and Ian E Smith

Citation: Breast Cancer Research 2007 9(Suppl 2):S13

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Adjuvant treatment: the contribution of expression microarrays

Authors: Per Eystein Lønning, Ranjan Chrisanthar, Vidar Staalesen, Stian Knappskog and Johan Lillehaug

Citation: Breast Cancer Research 2007 9(Suppl 2):S14

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Current and future choices in endocrine therapy

Authors: Matthew Ellis

Citation: Breast Cancer Research 2007 9(Suppl 2):S15

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Introduction: challenging established dogma

Authors: Richard J Santen

Citation: Breast Cancer Research 2007 9(Suppl 2):S16

Content type: Section introduction Published on: 20 December 2007
- View Full Text
- View PDF
Does presurgical treatment destroy important prognostic information

Authors: J Michael Dixon

Citation: Breast Cancer Research 2007 9(Suppl 2):S17

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Surrogates are just surrogates, but helpful just the same

Authors: Carol Fabian

Citation: Breast Cancer Research 2007 9(Suppl 2):S18

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Do classical oestrogen markers predict for clinical response to endocrine therapy?

Authors: William R Miller

Citation: Breast Cancer Research 2007 9(Suppl 2):S19

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
The origins of oestrogen receptor negative breast cancer

Authors: D Craig Allred

Citation: Breast Cancer Research 2007 9(Suppl 2):S20

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
The oestrogen paradox: an hypothesis

Authors: Richard J Santen

Citation: Breast Cancer Research 2007 9(Suppl 2):S21

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Oestrogen is bad for patients with breast cancer?

Authors: V Craig Jordan, Eric A Ariazi, Joan S Lewis-Wambi, Ramona R Swaby, Heather E Cunliffe, Anna T Riegel and Anton Wellstein

Citation: Breast Cancer Research 2007 9(Suppl 2):S22

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Introduction to clinical research sessions

Authors: James N Ingle

Citation: Breast Cancer Research 2007 9(Suppl 2):S23

Content type: Section introduction Published on: 20 December 2007
- View Full Text
- View PDF
Oxford Overview

Authors: James N Ingle

Citation: Breast Cancer Research 2007 9(Suppl 2):S24

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Endocrine and targeted treatments for breast cancer

Authors: Clifford A Hudis

Citation: Breast Cancer Research 2007 9(Suppl 2):S25

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Clinical outcomes: to be a surrogate or not to be ...?

Authors: David Cameron

Citation: Breast Cancer Research 2007 9(Suppl 2):S26

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF
Metabolic approaches to breast cancer treatment and prevention

Authors: Anthony Howell

Citation: Breast Cancer Research 2007 9(Suppl 2):S27

Content type: Short communication Published on: 20 December 2007
- View Full Text
- View PDF

Controversies in breast cancer

Short communications

Preface: controversies in breast cancer

Psychosocial controversies in breast cancer

The case for user involvement in research: the research priorities of cancer patients

Why patient representation might harm science?

A personal viewpoint against the motion that breast cancer patient advocacy groups unfairly distort the cancer budget

Is breast cancer advocacy distorting the cancer budget to the disadvantage of other tumours?

Why patient recorded outcomes should be mandatory in and outside clinical trials to guide management of patients with metastatic breast cancer

Decision making in local therapy for breast cancer

Benefits of complementary therapies

The dangers of complementary therapy

Introduction to sessions on Personalising treatment

Personalized surgical treatment of breast cancer

Short-term presurgical treatment for all?

Adjuvant treatment: the contribution of expression microarrays

Current and future choices in endocrine therapy

Introduction: challenging established dogma

Does presurgical treatment destroy important prognostic information

Surrogates are just surrogates, but helpful just the same

Do classical oestrogen markers predict for clinical response to endocrine therapy?

The origins of oestrogen receptor negative breast cancer

The oestrogen paradox: an hypothesis

Oestrogen is bad for patients with breast cancer?

Introduction to clinical research sessions

Oxford Overview

Endocrine and targeted treatments for breast cancer

Clinical outcomes: to be a surrogate or not to be ...?

Metabolic approaches to breast cancer treatment and prevention

Follow

Annual Journal Metrics

Breast Cancer Research

Contact us